Occlusive structure

The expansion of our knowledge of the structure and function of Na,K-ATPase is reflected in a rapid succession of reviews on Na,K-ATPase genes and regulation of expression [17], subunit assembly and functional maturation [20], the isozymes of Na,K-ATPase [18], and the stability of a subunit isoforms during evolution [21], physiological aspects and regulation of Na,K-ATPase [22], reconstitution and cation exchange [23], chemical modification [24], and occlusion of cations [25]. Other valuable sources are the review articles [26] and recent developments [27] reported at the International Na,K-pump Conference in September 1990. 

The membrane-bound preparation from kidney is easily solubilized in non-ionic detergent and analytical ultracentrifugation shows that the preparation consists predominantly (80 85%) of soluble af units with 143000 [28]. The soluble a)S unit maintains full Na,K-ATPase activity, and can undergo the cation or nucleotide induced conformational transitions that are observed in the membrane-bound preparation. A cavity for occlusion of 2K or 3Na ions can be demonstrated within the structure of the soluble a)S unit [29], as an indication that the cation pathway is organized in a pore through the aji unit rather than in the interphase between subunits in an oligomer. 

Transition from the high-energy phosphoform E]P[3Na] to the K-sensitive E2P[2Na] of Na,K-ATPase are accompanied by conformational transitions in protein structure and changes of the capacity and orientation of cation sites. In the Ej form of Na,K-ATPase, the exposure of Chys (Leu ) and Trys (Arg ) to cleavage reflects that the cation sites of the phosphoprotein are in a conformation oriented towards the cytoplasm with a capacity for occlusion of three Na ions. The E2 form... 

Transduction of the energy from ATP to movement of the cations may involve long-range structural transitions in the protein since ATP binding and phosphorylation takes place in the large cytoplasmic protrusion of the a subunit, while cation sites may be located in intramembrane domains. It is therefore important to establish relationships between the structural changes in the a subunit and ion binding or occlusion to see if the different exposure of bonds to proteolysis reflect the orientation and specificity of the cation sites. 

Portal hypertension is a consequence of increased resistance to blood flow through the portal vein. Increased resistance is usually due to restructuring of intrahepatic tissue (sinusoidal damage) but may also be caused by presinusoidal damage such as portal vein occlusion from trauma, malignancy, or thrombosis. A third (and the least common) mechanism is outflow obstruction of the hepatic vein. This latter damage is posthepatic, and normal liver structure is maintained. This chapter will focus on portal hypertension caused by intrahepatic damage from cirrhosis. 

It is generally not recommended to mix medications directly into the EN formula because of concerns that physical incompatibilities between the medications and the formula might lead to tube occlusion. There is some evidence that polymeric formulas are more likely to demonstrate physical incompatibility with medications compared with monomeric formulas, although most of the work in this area has used casein or caseinate-based formulas, and other proteins may act differently.38 The limited data currently available would indicate that acidic syrups and elixirs may be the worst for causing physical incompatibility when admixed with EN formulas. It has been postulated that this incompatibility is due to changes in the protein structure after exposure to acid or alcohol.38... 

Although HU may mediate some of its clinical benefits through its positive effect on HbF expression, these data also suggest that it may, by a yet-to-be defined mechanism of action, modulate the clinical severity of SCA. One possible pathway is that among the two incriminated interacting cell partners (sickle erythrocyte and endothelial cell) involved in vaso-adhesion and occlusion, HU may also affect the phenotype status of endothelial cells so that its adhesogenic (structural) and/or vasoregulatory (functional) properties are modified in a favorable manner. 

Lack of adhesion of a dental restoration to tooth structure results in microleakage at tooth-restoration interface. This occurrence can result in discoloration at the margin of the restoration, or in the formation of caries. Occlusal forces on the restoration and differences between the coeffidents of thermal expansion of the cement and tooth material can lead to leakage. In addition, oral fluids and moisture may affect the adhesion. Microleakage of composite resin restorations has been reviewed by Ben-Amar [233]. Microleakage is not as serious a problem with glass-ionomer cements as it is with resin-based restorative materials, due to reduced polymerization shrinkage [234]. 

Administration of a cocktail containing eicosapentenoic acid and docosahexenoic acid to volunteers for up to 6 weeks, resulted in a significant depression in IL-1J3 (61%), IL-1 a (39%), and TNF (40%) synthesis. These levels returned to normal after a few weeks [99]. In vitro studies indicate that Pentoxifylline can block the effects of IL-1 and TNF on neutrophils [100]. It is a phosphodiesterase (PDE) inhibitor that causes increased capillary blood flow by decreasing blood viscocity and is used clinically in chronic occlusive arterial disease of the limbs with intermittent claudication. Denbufylline, a closely related xanthine, has been patented as a functional inhibitor of cytokines and exhibits a similar profile to Pentoxifylline [101]. Romazarit (Ro-31-3948) derived from oxazole and isoxazole propionic acids has been shown to block IL- 1-induced activation of human fibroblasts in vitro and in animal models reduces inflammation [102,103,104]. By using a spontaneous autoimmune MRL/lpr mouse model, a significant efficacy was shown [105]. Two-dimensional structures of some of these molecules are shown in Figure 14. 

---